Solid dispersion: An efficient tool for increasing bioavailibility of poorly soluble drugs

International Journal of Pharmaceutical Sciences Review and Research

Volumn 8, Issue 1, 2011, Pages 37-52

  Sonpal, R N ^a   Lalwani, A N ^b   Darji, Vinay C ^c   Patel, Kaushik R ^c  

^a SHARDA UNIVERSITY   (India)

^b K B INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

^c Sharda School of Pharmacy   (India)

Author keywords

Bioavailability; Carrier; Dissolution; Solid dispersion; Solubility

Indexed keywords

CAPTOPRIL; DRUG CARRIER; ETRAVIRINE; GRISEOFULVIN; HYDROCHLOROTHIAZIDE; IBUPROFEN; ITRACONAZOLE; NABILONE; POLYMER; RITONAVIR; ROSUVASTATIN; SURFACTANT; TACROLIMUS;

ARTICLE; CAPSULE FILLING; CHEMICAL STRUCTURE; CRYSTALLIZATION; DISPERSION; DRUG ABSORPTION; DRUG ADMINISTRATION ROUTE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG INCOMPATIBILITY; DRUG SOLUBILITY; DRUG SOLUTION; DRUG STABILITY; DRUG SYNTHESIS; HIGH THROUGHPUT SCREENING; MELTING POINT; MISCIBILITY; PARTICLE SIZE; POROSITY; PRECIPITATION; REPRODUCIBILITY; SCALE UP; SCANNING ELECTRON MICROSCOPY; SOLID DISPERSION; SOLID STATE; SURFACE PROPERTY; SUSPENSION; WETTABILITY;

EID: 79957647698     PISSN: None     EISSN: 0976044X     Source Type: Journal    
DOI: None     Document Type: Article

References (82)

1. Lachman L., Liberman H.A, theory and practice of industrial pharmacy, 3 rd edition, 1998; 462-464
2. Encyclopedia of Pharmaceutical Technology, Marcel Dekker, 2002; 2458-2478
3. Leuner, C. and Dressman, J., Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm, 2000; 47-60.
4. www.worldsscibwks.com
5. Lipinski CA Avoiding investment in doomed drugs, is poor solubility an industry wide problem? Curr Drug Dis., 4: 2001; 17-19.
6. Birdar V. S., Arpana R. Patil, Guditi V. Sudarshan and Varsha B. Pokharkar, A comparative study of approaches improve solubility of roxithromycin, Int. J. Pharm., 2006; 22-32
7. Chaudhari P.D., Current trend in solid dispersion techniques,www.pharmainfo.net, 2006; 2-12
8. th Edition, 1991; 46, 75-78
9. Remingtons Pharmaceutical Sciences, 1980
10. Dirk-Jan van Drooge, Wouter L.J. Hinrichs, Bastiaan H.J. Dickhoff, Marco N.A. Elli, Marine Spray freeze drying to produce a stable 9-tetrahydrocannabinol containing inulinbased solid dispersion powder suitable for inhalation, Eur. J. Pharm. Biopharm, 2005; 231-240.
11. Brahmankar DM, Jaiswal SB. Absorption. In Brahmankar DM editors. A text book of Bio pharmaceutics and pharmacokinetics A Treatise; 1st Edition, vallabh prakashan New delhi; 1995, 20,297
12. Michael Aulton in pharmaceutics- A science of dosage from; particle size reduction; 1991 150-160
13. rd ed. 1991; 221
14. Chiou, W.L., Rigelman, S., 1971.Pharmaceutical application of solid dispersion system.J.Pharm.Sci.60, 1281-1302.
15. Sekiguchi, K; Obi, N. Studies on absorption of eutectic mixture. I A comparison of the behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man. Chem. Pharm. Bull., 1961, 9, 866-872.
16. Goldberg, A. H.; Galbaldi, M.; Kanig, K.L. Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures III. Experimental evaluation of griseofulvin-succinic acid solution. J. Pharm. Sci. 1966, 55, 487-492.
17. Christensen KL, Design of Redispersible Dry Emulsion: A Potential Oral Drug Delivery System. PhD Thesis 2000: 35-45.
18. Pouton CW. ''Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'selfmicroemulsifying' drug delivery systems''. Eur. J. Pharm. Sci. 2000; 11 Suppl. 2; 93-98
19. David J. H, ''Lipid-Based Systems for Oral Drug Delivery. Enhancing the Bioavailability of Poorly Water Soluble Drugs'' APR, 2002; 5; 88-93.
20. Muhammad J. Habib, Pharmaceutical solid dispersion technology, Technomic publication, USA, 2000; 27-95
21. V. Kamalakkannan et al. Solubility enhancement of poorly soluble drugs by solid dispersion technique - A review Journal of Pharmacy Research 2010, 3(9),2314-2321
22. Breitenbach J. Melt extrusion: from process to drug delivery technology. Eur. J. Pharm. Biopharm., 2002; 54(2): 107-117.
23. Mullins JD and Macek TJ. Some pharmaceutical properties of novobiocin. J. Am. Pharm. Assoc. Sci.Ed., 1960; 49: 245-248.
24. Goldberg AH, Gibaldi M and Kanig JL. Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures. I. Theoretical considerations and discussion of the literature. J. Pharm. Sci., 1965; 54(8): 1145-1148.
25. Rastogi RP and Rama Varma KT. Solid-liquid equilibria in solutions of non-electrolytes. J. Chem.Soc., 1956; 2: 2097-2101.
26. Wilcox WR, Friedenberg R and Back N. Zone melting of organic compounds. Chem. Rev., 1964; 64: 187-220.
27. Chiou WL and Riegelman S. Preparation and dissolution characteristics of several fast-release solid dispersions of griseofulvin. J. Pharm. Sci., 1969; 58(12): 1505-1510.
28. Sarkari M, Brown J, Chen X, Swinnea S, Williams RO. Enhanced drug dissolution using evaporative precipitation into aqueous solution. Int. J. Pharm., 2002; 243(1-2): 17-31.
29. Simonelli AP, Mehta SC and Higuchi WI. Dissolution rates of high energy polyvinylpyrrolidone (PVP)-sulfathiazole coprecipitates. J. Pharm. Sci., 1969; 58(5): 538-549.
30. Jain R K, Sharma D K, Jain S, Kumar S and Dua J S. Studies on solid dispersions of nimesulide with pregelatinized starch. Biosciences, biotechnology research Asia 3(1a), 2006, 151-153.
31. Kakumanu VK, Bansal AK. Supercritical fluid technology in pharmaceutical research. CRIPS. 2003; 4:8-12. (83)
32. Tanaka N, Imai K, Okimoto K, Ueda S, Rinta Ibuki Y T, Higaki K and Kimura T. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): In vivo evaluation. Journal of controlled release 122, 2006, 51-56. (3)
33. Rahul Ghaste, Solid Dispersions: An Overview, Latest Reviews; 2009, Vol. 7, Issue. 5
34. Goldberg A, Gibaldi M, Kanig L, ''Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures II experimental evaluation of a eutectic mixture: urea-acetaminophen system'', J. Pharm. Sci. 1966; 55; 482-487
35. Hume-Rotherly W, Raynor G V, ''The Structure of Metals and Alloys'', Institute of Metals, London, 1954.
36. Reed-Hill R E, ''Physical Metallurgy Principles'', Van- Nostrand, Princetown, NJ, 1964.
37. Forster A, Hempenstall, J, Tucker I and Rades T. Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis. Int. J. Pharm., 2001; 226(1- 2): 147-161.
38. Langer M, Höltje M, Urbanetz NA, Brandt B, Höltje HD and Lippold BC. Investigations on the predictability of the formation of glassy solid solutions of drugs in sugar alcohols. Int. J. Pharm., 2003; 252(1-2): 167-179.
39. Patidar Kalpana et al. Solid Dispersion: Approaches, Technology involved, Unmet need & ChallengesDrug Invention Today 2010, 2(7),349-357
40. Karanth H, Shenoy VS, Murthy RR. Industrially Feasible Alternative Approaches in the Manufacture of Solid Dispersions: A Technical Report. AAPS Pharm Sci Tech. 2006; E1-E8.
41. Tsinontides S C, Rajniak P, Hunke W A, Placek J, ''Freeze drying-principles and practice for successful scale-up to manufacturing'', Int. J. Pharm., 2004;280(1); 1-16.
42. Vilhelmsen T, Eliasen H, Schaefer T. ''Effect of a melt agglomeration process on agglomerates containing solid dispersions'' Int. J. Pharm., 2005; 303(1-2); 132-142.
43. Seo A, Schaefer T., ''Melt agglomeration with polyethylene glycol beads at a low impeller speed in a high shear mixer'' Eur. J. Pharm. Biopharm., 2001; 52(3); 315-325.
44. Bai J, Yaoxian L, Songtao Y, Jianshi D, Shugang W, Jifu Z, Yongzhi W, Qingbiao Y and Xuesi C X J. A simple and effective route for the preparation of poly (vinyl alcohol) (PVA) nanofibers containing gold nanoparticles by electrospinning method. Solid State Communications 141, 2007, 292-295
45. Johnson, D. M. and W.F. Taylor. Degradation of feprostalene in polyethylene glycol 400 solution. Eur. J. Pharm Sci 73: 1984. 1414-1417.
46. Law SL, Lo WY, Lin FM, Chaing CH. Dissolution and absorption of nifedipine in poly (ethylene glycol) solid dispersion containing phosphatidylcholine. Int J Pharm. 1992; 84:161-166.
47. Verreck G, Chun I, Peeters J, Rosenblatt J and Brewster ME. Preparation and characterization of nano fibers containing amorphous drug dispersions generated by electrostatic spinning. Pharm. Res., 2003; 20:810-817.
48. Hayes, Davis, Morella and Angelo Mario. Pharmaceutical compositions for poorly watersoluble drugs. United States Patent. No. 6881745, 2005.
49. Forster, A., J. Hempenstall, and T. Rades. 2001. haracterization of glass solutions of poorly water soluble drugs produced by melt extrusion with hydrophilic amorphous polymers J.Pharm Pharmacol 53: 303-315.
50. Ghebremeskel A N, Vemavarapu C and Lodaya M., ''Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: Selection of polymer surfactant combinations using solubility parameters and testing the processability'', Int. J. Pharm.,2007;308; 119-129.
51. Zhang R, Somasundaran P, ''Advances in adsorption of surfactants and their mixtures at solid/solution interfaces. Advances in colloid and interface science'', Int. J. Pharm, 2006;123; 213-229
52. Dhirendra k, Lewis S, Udupa N and Atin K, Solid Dispersions: A Review Pak. J. Pharm. Sci., Vol.22, No.2, April 2009, pp.234-246
53. Padma Priya S, A Novel Captopril Hydrochlorothiazide Solid Dispersion, International Journal of Pharmacy and Pharmaceutical Sciences Vol 2, Issue 2, 2010
54. Van Drooge, D.J., Hinrichs, W.L.J., and Frijlink, H.W., Anomalous dissolution behaviour of tablets prepared from sugar glass-based solid dispersions. J. Controlled Release, 2004;64-78.
55. Kaushal AM, Gupta P and Bansal AK. Amorphous drug delivery systems: molecular aspects, design, and performance. Crit. Rev. Ther. Drug Carrier Syst., 2004; 21(3): 133-193.
56. Bugay DE. Characterization of the solid-state: spectroscopic techniques. Adv. Drug Deliv. Rev., 2001; 48(1): 43-65.
57. Taylor LS and Zografi G. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm. Res., 1997; 14: 1691-1698.
58. Taylor LS and Zografi G. The quantitative analysis of crystallinity using FT-Raman spectroscopy. Pharm. Res., 1998; 15(5): 755-761.
59. Broman E, Khoo C and Taylor LS. A comparison of alternative polymer excipients and processing methods for making solid dispersions of a poorly water soluble drug. Int. J. Pharm., 2001; 222(1): 139-151.
60. Buckton G and Darcy P. The use of gravimetric studies to assess the degree of crystallinity of predominantly crystalline powders. Int. J. Pharm., 1995; 123: 265-271.
61. Sebhatu T, Angberg M and Ahlneck C. Assessment of the degree of disorder in crystalline solids by isothermal microcalorimetry. Int. J. Pharm., 1994; 104: 135-144.
62. Pikal MJ, Lukes AL, Lang JE and Gaines K. Quantitative crystallinity determinations for betalactam antibiotics by solution calorimetry: correlations with stability. J. Pharm. Sci., 1978; 67(6): 767-73.
63. Kerc J and Srcic S. Thermal analysis of glassy pharmaceuticals. Thermochim. Acta., 1995; 248: 81-95.
64. Breitenbach J, Schrof W and Neumann J. Confocal Ramanspectroscopy: analytical approach to solid dispersions and mapping of drugs. Pharm. Res., 1999; 16(7): 1109-1113.
65. Li J, Guo Y and Zografi G. The solid-state stability of amorphous quinapril in the presence of beta-cyclodextrins. J. Pharm. Sci., 2002; 91(1): 229-243.
66. Rogers TL, Hu JH, Brown J, Young T, Johnston KP and Williams RO. A novel particle engineering technology to enhance dissolution of poorly water soluble drugs: sprayfreezing into liquid. Eur. J. Pharm. Biopharm., 2002; 54(3): 271-280.
67. De Meuter P, Rahier H and Van Mele B. The use of modulated temperature differential scanning calorimetry for the characterisation of food systems. Int. J. Pharm., 1999; 192(1): 77-84.
68. Cilurzo F, Minghetti P, Casiraghi A and Montanari L. Characterization of nifedipine solid dispersions. Int. J. Pharm., 2002; 242(1-2): 313-317.
69. Vasanthavada M, WQ Tong, Y Joshi and MS Kislalioglu. Phase behavior of amorphous molecular dispersions I: Determination of the degree and mechanism of solid solubility. Pharm. Res., 2004; 21(9): 1598-1606.
70. Sekiguchi and obi, chem. ''Mechanism of dissolution of fast release solid dispersion.'' pharm. Bull; 1961; 9, 866
71. Toshiaki Nishihata, Yoshiko Chigawa, Akira Kamada, Kiyoshi Sakai, Koichi Mastumoto, Kazuhoko Shinozaki, Yujin Tabata, ''Griseofulvin- Hydrogenated Soya Phospholipid Coprecipitates'' Drug Development and Industrial Pharmacy, Volume 14, Issue 9 June 1988, pages 1137-1154.
72. Darío Leonardi, María Gabriela Barrera, María Celina Lamas, and Claudio, Javier Salomón. ''Development of Prednisone:Polyethylene Glycol 6000 Fast- Release Tablets From Solid Dispersions: Solid-State Characterization, Dissolution Behavior, and Formulation Parameters''. AAPS PharmSciTech 2007; 8 (4) Article 108.
73. P. Mura, A. Manderioli, G. Bramanti, L. Ceccarelli, ''Properties of Solid Dispersions of Naproxen in Various Polyethylene Glycols''. Drug Development and Industrial Pharmacy, Volume 22, Issue 9 & 10 September 1996, pages 909-916.
74. Arias MJ, Gines JM, moyano JR, Preze Barrales MJ and Vela MT, Rabasco AM. ''Improvement of the diuretic effect of triamterene via solid dispersion technique with PEG 4000.'' EUR-J-Drug Metab Pharacokinet; 1994; 19(4), 295-302.
75. Mariko Iwata, Haruhisa Ueda, ''Dissolution Properties of Glibenclamide in Combinations with Polyvinylpyrrolidone'' Drug Development and Industrial Pharmacy, Volume 22, Issue 11 November 1996, pages 1161-1165.
76. S. Anguiano-Igea, F. J. Otero-Espinar, J. L. Vila-Jato and J. Blanco-Méndez; ''The properties of solid dispersions of clofibrate in polyethylene glycols''. Pharmaceutica Acta Helvetiae; Volume 70, Issue 1, April 1995, Pages 57-66.
77. Trapani G.; Franco M.; Latrofa A; Pantaleo M.R; Provenzano M.R.; Sanna E.; Maciocco E; liso G; ''Physicochemical characterization and in vivo properties of Zolpidem in solid dispersions with polyethylene glycol 4000 and 6000''. International journal of pharmaceutics; 1999, vol. 184, pp. 121-130
78. Kohri N, Yamayoshi Y, Xin H, Iseki K, Sato N, Todo S and Miyazaki K, ''Improving the oral bioavailability of albendazole in rabbits by the solid dispersion technique''. J Pharm Pharmacol; 1999; 51(2) 159-64
79. Samy EM, Hassan MA, Tous SS, Rhodes CT ''Improvement of availability of Allopurinol from pharmaceutical dosage forms I - suppositories''. Eur J Pharm Biopharm; 2000; 49(2) 119-27
80. Chiou Wl and Riegelman S, ''Pharmaceutical Applications Of Solid Dispersion Systems'' J Pharma Sci; 1971; 60; 1281-302
81. Chalmers MJ, Clinical and Exp. Hypertension (New York); 1999; 21(5-6)875-84.
82. Sica, Domenic A. Rationale for Fixed-Dose Combinations in the Treatment of Hypertension: Drugs: 2002; 62(3): 443-462.